Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
暂无分享,去创建一个
Jamie R. Kutasovic | A. Vargas | S. Lakhani | G. Chenevix-Trench | K. Khanna | P. Simpson | M. Askarian-Amiri | C. Smart | F. Al-Ejeh | J. Saunus | Mariska S. Miranda | A. M. McCart Reed | L. Reid | S. Cocciardi | R. Johnston | P. Kalita-de Croft | E. Rozali | L. Wockner | A. Dalley | Debina Sarkar | Julie K Johnson | Eva Lorsy | T. Seidens
[1] S. Lakhani,et al. The Brisbane Breast Bank , 2018 .
[2] Dmitriy Sonkin,et al. TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data , 2016, Human mutation.
[3] N. Rosenfeld,et al. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma , 2016, The journal of pathology. Clinical research.
[4] Harold L. Moses,et al. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection , 2016, PloS one.
[5] S. Lakhani,et al. High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations , 2016, Breast Cancer Research.
[6] Vidudala VTS Prasad,et al. Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014 , 2015, npj Breast Cancer.
[7] Laura M. Heiser,et al. Modeling precision treatment of breast cancer , 2013, Genome Biology.
[8] A. Vargas,et al. In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity , 2013, PloS one.
[9] A. Nerlich,et al. Density-dependent lineage instability of MDA-MB-435 breast cancer cells , 2013, Oncology letters.
[10] G. Buchanan,et al. An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. , 2012, Endocrine-related cancer.
[11] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[12] X. Chen,et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.
[13] S. Schnitt,et al. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines , 2010, Breast Cancer Research.
[14] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[15] Jason I. Herschkowitz,et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.
[16] Stephen Fox,et al. HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer , 2010, Breast Cancer Research.
[17] Hans Clevers,et al. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines , 2010, Breast Cancer Research and Treatment.
[18] Elgene Lim,et al. Open Access Research Article Transcriptome Analyses of Mouse and Human Mammary Cell Subpopulations Reveal Multiple Conserved Genes and Pathways , 2022 .
[19] A. Hollestelle,et al. Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma? , 2009, Cancer research.
[20] John D. Minna,et al. Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery , 2009, PloS one.
[21] A. Chambers,et al. MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? , 2009, Cancer research.
[22] Charlotte Kuperwasser,et al. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy , 2008, Breast Cancer Research.
[23] Chad J. Creighton,et al. MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research , 2007, Breast Cancer Research and Treatment.
[24] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[25] Daniel Birnbaum,et al. Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications , 2003, BMC Cancer.
[26] P. Guldberg,et al. Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients , 2000, Breast Cancer Research.
[27] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .